Approved to treat different types of advanced non–small cell lung cancer (NSCLC) with certain EGFR mutations

Select a type of lung cancer treatment
Not sure which of the options above to select?
Ask your doctor and learn more about the types of lung cancer RYBREVANT® is approved to treat.
Learn about the optionsNext arrow icon
A patient story
Meet Jimmy, a real patient treated with RYBREVANT®

Jimmy’s Story

Meet Jimmy, a patient treated with RYBREVANT®. Hear about his experience and why sharing his story is important to him.

Doctor Discussion Guide

Tips and example questions for having a helpful discussion with your doctor.

RYBREVANT® doctor discussion guide thumbnailRYBREVANT® doctor discussion guide thumbnail

Savings & Support

Once prescribed a RYBREVANT®-based treatment, connect with a Care Navigator for your support needs.

Rybrevant® with meRybrevant® with me
EGFR = epidermal growth factor receptor